Actinium Pharmaceuticals, Inc.
ATNM
$1.26
$0.1614.55%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.94M | -5.13M | -6.88M | -15.94M | -6.65M |
| Total Depreciation and Amortization | 206.00K | 206.00K | 204.00K | 205.00K | 204.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.00K | 109.00K | 197.00K | 8.87M | 1.20M |
| Change in Net Operating Assets | 435.00K | -1.51M | 1.09M | -715.00K | -506.00K |
| Cash from Operations | -5.29M | -6.33M | -5.39M | -7.57M | -5.75M |
| Capital Expenditure | -104.00K | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -104.00K | -- | -- | -- | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3.00K | -2.00K | -3.00K | -2.00K | -2.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 0.00 | -207.00K | -- | -- | -1.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -3.00K | -209.00K | -3.00K | -2.00K | -3.00K |
| Foreign Exchange rate Adjustments | 6.00K | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.39M | -6.53M | -5.40M | -7.58M | -5.75M |